Recurrence after treatment of micropapillary thyroid cancer

Thyroid

Volumn 19, Issue 10, 2009, Pages 1043-1048

  Ross, Douglas S ^a   Litofsky, Danielle ^b   Ain, Kenneth B ^c   Bigos, Thomas ^d   Brierley, James D ^e   Cooper, David S ^f   Haugen, Bryan R ^g   Jonklaas, Jacqueline ^h   Ladenson, Paul W ^f   Magner, James ⁱ   Robbins, Jacob ^j   Skarulis, Monica C ^j   Steward, David L ^k   Maxon, Harry R ^k   Sherman, Steven I ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d MAINE MEDICAL CENTER   (United States)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

ⁱ GENZYME CORPORATION   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

^k UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MICROPAPILLARY THYROID CANCER; PRIORITY JOURNAL; THYROID CANCER; THYROIDECTOMY;

ADULT; AGE FACTORS; AGED; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; REGISTRIES; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 70350632900     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0407     Document Type: Article

References (20)

1. Wang C, Crapo LM 1997 The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26:189-218.
2. Harach HR, Franssila KO, Wasenius VM 1985 Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 56:531-538.
3. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK 2006 SEER Cancer Statistics Review, 1975-2003. National Cancer Institute, Bethesda, MD. http:==seer.cancer.gov=csr=1975-2003=.
4. Ross DS 2006 Editorial: Predicting thyroid malignancy. J Clin Endocrinol Metab 91:4253-4255.
5. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
6. Chow S-M, Law SCK, Au S-K, Mang O, Yau S, Kuen KT, Lau WH 2003 Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000. Clin Oncol 15:329-336.
7. Mazzaferri EL 2007 Management of low-risk differentiated thyroid cancers. Endocr Pract 13:498-512.
8. Hay ID 2007 Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 13:521-533.
9. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16: 109-142.
10. Udelsman R, Lakatos E, Ladenson P 1996 Optimal surgery for papillary thyroid carcinoma. World J Surg 20:88-93.
11. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI 2006 Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16:1229-1242.
12. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Taylor T, Maxon HR 1998 Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012-1021.
13. Taylor T, Specker B, Robbins J, Sperling M, Ho M, Ain K, Bigos ST, Brierley J, Cooper D, Haugen B, Hay I, Hertzberg V, Klein I, Klein H, Ladenson P, Nishiyama R, Ross D, Sherman S, Maxon HR 1998 Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 129:622-627. (Pubitemid 28480817)
14. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, Ain K, Bigos ST, Brierley JD, Haugen BR, Klein I, Robbins J, Sherman SI, Taylor T,Maxon HR 1998 Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 8:737-744.
15. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139-1147.
16. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M 1998 Microcarcinoma of the thyroid gland. The Gustave-Roussy Institute experience. Cancer 83:553-559.
17. Yamashita H, Noguchi S, Murakami N, Toda M, Uchnio S, Watanabe S, Kawamoto H 1999 Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer 86:842-849.
18. Chow S-M, Law SCK, Chan JKC, Au SK, Yau S, Lau WH 2003 Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40.
19. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A 2004 Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713-3720.
20. Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Dogli Uberti EC 2006 Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a restrospective study in 243 patients. J Clin Endocrinol Metab 91:2171-2178.